Benjamin
D.
Moncarz
Leadership Role
Chief Financial Officer - Office of Finance, Budget and Acquisitions
Benjamin D. Moncarz serves as the Chief Financial Officer (CFO) for the U.S. Food and Drug Administration , where he oversees the agency’s financial management, budget, acquisitions, and user fees. In this role, he is responsible for the management and oversight of approximately $7 billion in annual resources, including about $3.5 billion in user fee funding, ensuring effective stewardship, accountability, and alignment of resources in support of the FDA’s public health mission.
Since joining the FDA in 2022, Mr. Moncarz has led efforts to strengthen the agency’s financial management, budget execution, and acquisition oversight. His tenure has focused on enhancing financial governance, supporting mission-critical public health programs, and advancing operational efficiency across the agency. This includes advancing the centralization and modernization of the FDA’s user fee financial management, improving consistency, transparency, and efficiency in the administration of multiple user fee programs that support the agency’s regulatory and public health mission.
Prior to joining the FDA, Mr. Moncarz brought nearly 15 years of distinguished federal leadership experience at the Department of Homeland Security (DHS). During his tenure at DHS, Mr. Moncarz served in various leadership positions at the Federal Emergency Management Agency (FEMA), including as Acting Chief Financial Officer, Deputy Chief Financial Officer, and Budget Director.
Mr. Moncarz holds a Bachelor of Arts in Economics from Duke University and a Master’s Certificate in Project Management from George Washington University.